Clinical Trials Using Calcium Release-activated Channels Inhibitor RP4010
Clinical trials are research studies that involve people. The clinical trials on this list are studying Calcium Release-activated Channels Inhibitor RP4010. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
Safety and Efficacy Study of RP4010, in Patients With Relapsed or Refractory Lymphomas
A Phase I / Ib, Study to Evaluate Safety and Efficacy of RP4010, in Patients with Relapsed or Refractory Lymphomas
Location: 4 locations